Literature DB >> 25564477

P65 inactivation in adipocytes and macrophages attenuates adipose inflammatory response in lean but not in obese mice.

Zhanguo Gao1, Jin Zhang2, Tara M Henagan3, Jong Han Lee2, Xin Ye2, Hui Wang4, Jianping Ye5.   

Abstract

NF-κB induces transcriptional expression of proinflammatory genes and antiapoptotic genes. The two activities of NF-κB remain to be characterized in the mechanism of chronic inflammation in obesity. To address this issue, we inactivated NF-κB in adipose tissue by knocking out p65 (RelA) in mice (F-p65-KO) and examined the inflammation in lean and obese conditions. In the lean condition, KO mice exhibited a reduced inflammation in adipose tissue with a decrease in macrophage infiltration, M1 polarization, and proinflammatory cytokine expression. In the obese condition, KO mice had elevated inflammation with more macrophage infiltration, M1 polarization, and cytokine expression. In the mechanism of enhanced inflammation, adipocytes and macrophages exhibited an increase in cellular apoptosis, which was observed with more formation of crown-like structures (CLS) in fat tissue of KO mice. Body weight, glucose metabolism, and insulin sensitivity were not significantly altered in KO mice under the lean and obese conditions. A modest but significant reduction in body fat mass was observed in KO mice on HFD with an elevation in energy expenditure. The data suggest that in the control of adipose inflammation, NF-κB exhibits different activities in the lean vs. obese condition. NF-κB is required for expression of proinflammatory genes in the lean but not in the obese condition. NF-κB is required for inhibition of apoptosis in the obese condition, in which proinflammation is enhanced by NF-κB inactivation.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  apoptosis; crown-like structure; inflammation; macrophage polarization; nuclear factor-κB

Mesh:

Substances:

Year:  2015        PMID: 25564477      PMCID: PMC4360014          DOI: 10.1152/ajpendo.00532.2014

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  60 in total

1.  Transcriptional control of adipose lipid handling by IRF4.

Authors:  Jun Eguchi; Xun Wang; Songtao Yu; Erin E Kershaw; Patricia C Chiu; Joanne Dushay; Jennifer L Estall; Ulf Klein; Eleftheria Maratos-Flier; Evan D Rosen
Journal:  Cell Metab       Date:  2011-03-02       Impact factor: 27.287

Review 2.  Type 2 diabetes as an inflammatory disease.

Authors:  Marc Y Donath; Steven E Shoelson
Journal:  Nat Rev Immunol       Date:  2011-01-14       Impact factor: 53.106

Review 3.  NF-κB, inflammation, and metabolic disease.

Authors:  Rebecca G Baker; Matthew S Hayden; Sankar Ghosh
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

4.  Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis.

Authors:  Davina Wu; Ari B Molofsky; Hong-Erh Liang; Roberto R Ricardo-Gonzalez; Hani A Jouihan; Jennifer K Bando; Ajay Chawla; Richard M Locksley
Journal:  Science       Date:  2011-03-24       Impact factor: 47.728

5.  Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure.

Authors:  Tianyi Tang; Jin Zhang; Jun Yin; Jaroslaw Staszkiewicz; Barbara Gawronska-Kozak; Dae Young Jung; Hwi Jin Ko; Helena Ong; Jason K Kim; Randy Mynatt; Roy J Martin; Michael Keenan; Zhanguo Gao; Jianping Ye
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

6.  Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice.

Authors:  Stephan Wueest; Reto A Rapold; Desiree M Schumann; Julia M Rytka; Anita Schildknecht; Ori Nov; Alexander V Chervonsky; Assaf Rudich; Eugen J Schoenle; Marc Y Donath; Daniel Konrad
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

7.  Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism.

Authors:  Anil Kumar; John C Lawrence; Dae Young Jung; Hwi Jin Ko; Susanna R Keller; Jason K Kim; Mark A Magnuson; Thurl E Harris
Journal:  Diabetes       Date:  2010-03-23       Impact factor: 9.461

8.  Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis.

Authors:  Naim Alkhouri; Agnieszka Gornicka; Michael P Berk; Samjhana Thapaliya; Laura J Dixon; Sangeeta Kashyap; Philip R Schauer; Ariel E Feldstein
Journal:  J Biol Chem       Date:  2009-11-24       Impact factor: 5.157

9.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

10.  Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes.

Authors:  Allison B Goldfine; Robert Silver; Waleed Aldhahi; Dongsheng Cai; Elizabeth Tatro; Jongsoon Lee; Steven E Shoelson
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

View more
  15 in total

1.  Quercus infectoria inhibits Set7/NF-κB inflammatory pathway in macrophages exposed to a diabetic environment.

Authors:  Julalak Chokpaisarn; Norifumi Urao; Supayang P Voravuthikunchai; Timothy J Koh
Journal:  Cytokine       Date:  2017-04-11       Impact factor: 3.861

2.  Inactivation of NF-κB p65 (RelA) in Liver Improves Insulin Sensitivity and Inhibits cAMP/PKA Pathway.

Authors:  Bilun Ke; Zhiyun Zhao; Xin Ye; Zhanguo Gao; Vincent Manganiello; Bin Wu; Jianping Ye
Journal:  Diabetes       Date:  2015-06-02       Impact factor: 9.461

3.  IRF3 promotes adipose inflammation and insulin resistance and represses browning.

Authors:  Manju Kumari; Xun Wang; Louise Lantier; Anna Lyubetskaya; Jun Eguchi; Sona Kang; Danielle Tenen; Hyun Cheol Roh; Xingxing Kong; Lawrence Kazak; Rasheed Ahmad; Evan D Rosen
Journal:  J Clin Invest       Date:  2016-07-11       Impact factor: 14.808

Review 4.  Regulation of immunometabolism in adipose tissue.

Authors:  Manju Kumari; Joerg Heeren; Ludger Scheja
Journal:  Semin Immunopathol       Date:  2017-12-05       Impact factor: 9.623

5.  Divergent functions of endotrophin on different cell populations in adipose tissue.

Authors:  Yueshui Zhao; Xue Gu; Ningyan Zhang; Mikhail G Kolonin; Zhiqiang An; Kai Sun
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-10-11       Impact factor: 4.310

6.  Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b.

Authors:  Suraj J Patel; Nan Liu; Sam Piaker; Anton Gulko; Maynara L Andrade; Frankie D Heyward; Tyler Sermersheim; Nufar Edinger; Harini Srinivasan; Margo P Emont; Gregory P Westcott; Jay Luther; Raymond T Chung; Shuai Yan; Manju Kumari; Reeby Thomas; Yann Deleye; André Tchernof; Phillip J White; Guido A Baselli; Marica Meroni; Dario F De Jesus; Rasheed Ahmad; Rohit N Kulkarni; Luca Valenti; Linus Tsai; Evan D Rosen
Journal:  Sci Transl Med       Date:  2022-03-23       Impact factor: 19.319

7.  Obesity-associated Inflammation Induces microRNA-155 Expression in Adipocytes and Adipose Tissue: Outcome on Adipocyte Function.

Authors:  Esma Karkeni; Julien Astier; Franck Tourniaire; Mouna El Abed; Béatrice Romier; Erwan Gouranton; Lin Wan; Patrick Borel; Jérôme Salles; Stéphane Walrand; Jianping Ye; Jean-François Landrier
Journal:  J Clin Endocrinol Metab       Date:  2016-02-01       Impact factor: 5.958

8.  IRF3 reduces adipose thermogenesis via ISG15-mediated reprogramming of glycolysis.

Authors:  Shuai Yan; Manju Kumari; Haopeng Xiao; Christopher Jacobs; Shihab Kochumon; Mark Jedrychowski; Edward Chouchani; Rasheed Ahmad; Evan D Rosen
Journal:  J Clin Invest       Date:  2021-04-01       Impact factor: 19.456

9.  NF-κB regulates brown adipocyte function through suppression of ANT2.

Authors:  Shiqiao Peng; Xiaoying Zhang; Lili Yu; Yanhong Xu; Yang Zhou; Shengnan Qian; Xinyu Cao; Xiaotong Ye; Jiajun Yang; Weiping Jia; Jianping Ye
Journal:  Acta Pharm Sin B       Date:  2021-10-29       Impact factor: 14.903

10.  PS-341 alleviates chronic low-grade inflammation and improves insulin sensitivity through the inhibition of TM4 (UBAC2) degradation.

Authors:  Lili Chen; Kuanping Ye; Xiaocheng Feng; Lianxi Li; Qin Li; Ying Huang; Xuanchun Wang; Rumei Li; Cheng Hu; Zhen Yang; Bin Lu; Yehong Yang; Jie Wen; Zhaoyun Zhang; Min He; Qinghua Wang; Wenbai Zhou; Yintao Li; Naijia Liu; Jinya Huang; Qiwei Shen; Qiyuan Yao; Renming Hu
Journal:  Nutr Metab (Lond)       Date:  2021-06-01       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.